RAC1
转移
骨转移
腺癌
医学
癌症研究
肺
内科学
病理
化学
癌症
生物化学
信号转导
作者
Xiaoshen Zhang,Xijun Liang,Yaokai Wen,Fengying Wu,Guanghui Gao,Lei Zhang,Yifeng Gu,Jianping Zhang,Zhou Fei,Wei Li,Liang Tang,Xiaojun Yang,Hui Zhao,Caicun Zhou,Fred R. Hirsch
出处
期刊:Cell Reports
[Cell Press]
日期:2024-07-24
卷期号:43 (8): 114528-114528
被引量:9
标识
DOI:10.1016/j.celrep.2024.114528
摘要
Macrophage-to-osteoclast differentiation (osteoclastogenesis) plays an essential role in tumor osteolytic bone metastasis (BM), while its specific mechanisms remain largely uncertain in lung adenocarcinoma BM. In this study, we demonstrate that integrin-binding sialoprotein (IBSP), which is highly expressed in the cancer cells from bone metastatic and primary lesions of patients with lung adenocarcinoma, can facilitate BM and directly promote macrophage-to-osteoclast differentiation independent of RANKL/M-CSF. In vivo results further suggest that osteolytic BM in lung cancer specifically relies on IBSP-induced macrophage-to-osteoclast differentiation. Mechanistically, IBSP regulates the Rac family small GTPase 1 (Rac1)-NFAT signaling pathway and mediates the forward shift of macrophage-to-osteoclast differentiation, thereby leading to early osteolysis. Moreover, inhibition of Rac1 by EHT-1864 or azathioprine in mice models can remarkably alleviate IBSP-induced BM of lung cancer. Overall, our study suggests that tumor-secreted IBSP promotes BM by inducing macrophage-to-osteoclast differentiation, with potential as an early diagnostic maker for BM, and Rac1 can be the therapeutic target for IBSP-promoted BM in lung cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI